Category: Regulatory

Hospital Groups Urge Supreme Court to Review DSH Payment Case with 340B Implications

February 8, 2024 William Newton, Associate Editor/Senior Writer Views

The Supreme Court of the United States building

Major hospital groups have asked the Supreme Court to review a case that challenges HHS' DSH payment formula.

Major hospital groups last week urged the U.S. Supreme Court to review a federal appeals court decision that upheld how [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment

February 6, 2024 Rich Daly, Editor in Chief Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel

February 1, 2024 William Newton, Associate Editor/Senior Writer Views

Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.

A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Tennessee Bills Introduced to Regulate 340B Funding for Certain STD Clinics

February 1, 2024 William Newton, Associate Editor/Senior Writer Views

Companion bills recently introduced in the Tennessee state house and senate would add regulations for 340B in-kind funding.

Tennessee state lawmakers have introduced companion bills that would require sexually transmitted disease (STD) clinics to enter into a contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Former Sen. Cassidy Aide, Trump Administration Executive Criticizes Requiring More Hospital 340B Reporting

January 30, 2024 Rich Daly, Editor in Chief Views

Brenda Destro, a former aide to a Republican senator and HHS official, recently wrote an op-ed that criticized hospital 340B transparency legislation.

A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

January 30, 2024 Rich Daly, Editor in Chief Views

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.

The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Systems, HRSA Spar in Federal Court Over 340B Registration Policy Reversal

January 30, 2024 William Newton, Associate Editor/Senior Writer Views

A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.

Forty-four health systems have asked a federal district court to decide, without a full trial, on their lawsuit against federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK, Vertex Offer Refunds to 340B Providers

January 30, 2024 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HIV/AIDS Group Continues Legal Fight with Apexus Over 340B Prime Vendor Contract

January 25, 2024 William Newton, Associate Editor/Senior Writer Views

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.

The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.

A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live